|| Checking for direct PDF access through Ovid
Single-nucleotide polymorphisms (SNPs) of neurologically relevant genes play a role in concussions from increasing susceptibility or hampering cognitive performance.The purpose of this study was to investigate the effects of polymorphisms of APOE, APOE promoter, COMT and DRD2 on baseline neurocognitive function and concussion history in collegiate student-athletes.Cross-sectional.Collegiate campus in North Carolina.262 (194 males, 68 females) collegiate student-athletes.Buccal mucosa swabs were collected from participants. SNP genotyping was run on all samples to determine APOE, APOE promoter, COMT, and DRD2 genotypes. Participants were split into three groups based on their genotypes for each gene.Participants completed the Immediate Post-Concussion Assessment and Cognitive Testing neurocognitive assessment which generated composite scores on Verbal Memory, Visual Memory, Visuomotor Speed, and Reaction Time as well as Impulse ControlNone of the genotype variables influenced number of concussions (p>0.05). MANOVA analysis determined no differences for APOE promoter and DRD2 genotypes (p>0.05). There were statistical differences for APOE for Visuomotor composite (APOE-e3 (m=41.2, %95 CI [40.8, 42.1]) vs e4 (m=39.1, %95 CI [37.8, 40.5], p=0.017) and Reaction Time (APOE-e4 (m=0.62, %95 CI [0.60, 0.64]) was different than both e2 (m=0.57, %95 CI [0.54, 0.60] and e3(m=0.58, %95 CI [0.56, 0.59], p<0.005). There were also differences for COMT for Impulse Control (Val/Val (m=6.2 %95 CI [5.4, 7.1]) was different Val/Met (m=4.7, %95 CI [4.1, 5.2] and Met/Met (m=4.7, %95 CI [3.8, 5.6], p<0.02).APOE and COMT single nucleotide polymorphisms lead to significant differences in neurocognitive performance at baseline but not concussion history.None.